Evolution Toward Severe Covid-19 From Biological Monitoring to Therapeutic Considerations

Front Immunol. 2020 Dec 15:11:562038. doi: 10.3389/fimmu.2020.562038. eCollection 2020.

Authors

Julien Carvelli^{1

2}, Audrey Le Saux¹, Jeremy Bourenne¹, Marc Gainnier¹, Gilles Kaplanski³

Affiliations

¹ Réanimation des Urgences, CHU Timone, AP-HM, Aix-Marseille Université, Marseille, France.
² Marseille Immunopôle, CHU Timone, AP-HM, Marseille, France.
³ Médecine Interne et Immunologie clinique, CHU Conception, AP-HM, Aix-Marseille Université, Marseille, France.

No abstract available

Keywords: C reactive protein; COVID-19; IL-6; SARS-CoV-2; cytokine storm.

Publication types

Observational Study

MeSH terms

Biological Monitoring / methods
COVID-19 / diagnosis*
COVID-19 / pathology*
Cytokine Release Syndrome / pathology
Cytokines / blood
Humans
SARS-CoV-2 / immunology
Severity of Illness Index*

Substances

Cytokines